Nutrition & Exercise Prehabilitation for Obesity-Related Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special program of nutrition and exercise can help American Indian patients with obesity-related cancer better prepare for surgery. Researchers seek to understand if this "prehabilitation" intervention can alter specific blood and tumor markers that indicate inflammation. The trial is recruiting participants diagnosed with obesity-related solid tumor cancer who are scheduled for surgery at least three weeks later. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance surgical outcomes for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are receiving chemotherapy during the preoperative study period, you would be excluded from participating.
What prior data suggests that this prehabilitation intervention is safe for American Indian patients with obesity-related cancer?
Research has shown that prehabilitation is generally safe for patients. One study found that prehabilitation safely reduced belly fat in obese patients with stomach cancer. Another study discovered that a high-protein prehabilitation program helped patients maintain their physical health during chemotherapy.
Most patients complete prehabilitation without major issues, as acceptance and completion rates remain high. Evidence suggests that prehabilitation can lead to shorter hospital stays and reduced time in intensive care.
Overall, these findings indicate that prehabilitation is well-tolerated and can improve recovery for patients undergoing surgery.12345Why are researchers excited about this trial?
Researchers are excited about the Prehabilitation Intervention for obesity-related cancer because it focuses on improving patient readiness for surgery through a tailored program combining nutrition and exercise. Unlike traditional treatments that primarily target the cancer itself, this intervention aims to enhance overall health and modify inflammatory biomarkers, potentially leading to better surgical outcomes. The unique aspect of this approach is its focus on a short, intensive pre-surgery period, which could offer patients a non-invasive way to boost recovery and resilience, setting a new standard for preoperative care.
What evidence suggests that this prehabilitation intervention is effective for obesity-related cancer?
Research has shown that preparing for surgery with exercise and good nutrition, known as prehabilitation, can lead to better surgery results and faster recovery. Studies have found that it can reduce belly fat by 17% and improve overall health. For cancer patients, prehabilitation is linked to better physical ability and less fatigue. It also decreases the chance of post-surgery complications. This trial will implement a tailored prehabilitation program for individuals with obesity-related cancers preparing for surgery, making it a promising option for improving outcomes in this patient group.46789
Who Is on the Research Team?
Jennifer Erdrich, MD
Principal Investigator
University of Arizona
Are You a Good Fit for This Trial?
This trial is for American Indian patients who have obesity-related cancers and are scheduled for surgery. It's designed to test a prehabilitation program that includes nutrition and exercise, aiming to improve their health before treatment.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prehabilitation Intervention
Participants engage in a tailored prehab program involving nutrition and exercise to modify inflammatory biomarkers before surgery
Follow-up
Participants are monitored for changes in inflammatory biomarkers and lifestyle behavior post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Prehabilitation Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
National Cancer Institute (NCI)
Collaborator